Application 022138
- Type
- NDA
- Sponsor
- SANOFI AVENTIS US
Application Products#
| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|---|---|---|---|---|---|
| 001 | LOVENOX | ENOXAPARIN SODIUM | INJECTABLE; INJECTION | 100MG/ML | No | No |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Enoxaparin Sodium | ENOXAPARIN SODIUM | Cardinal Health 107, LLC | 45a66675-b159-42b8-9f18-ff80f28e1503 | 2026-09-02 | Boxed warning, Warnings, Adverse reactions | ENOXAPARIN SODIUM |
| Lovenox | ENOXAPARIN SODIUM | Sanofi-Aventis U.S. LLC | 5017a927-2a24-4f27-89f9-27c805bf7d59 | 2026-05-28 | Boxed warning, Warnings, Adverse reactions | Lovenox ENOXAPARIN SODIUM |
| Enoxaparin Sodium | ENOXAPARIN SODIUM | Cardinal Health 107, LLC | 5e7568a6-cf8a-4de2-86ba-b94c8ab4c806 | 2026-05-05 | Boxed warning, Warnings, Adverse reactions | ENOXAPARIN SODIUM |
| Lovenox | ENOXAPARIN SODIUM | Cardinal Health 107, LLC | 3d263380-4f44-4fd8-aa2a-e69702ab258f | 2026-04-27 | Boxed warning, Warnings, Adverse reactions | Lovenox ENOXAPARIN SODIUM |
| Enoxaparin Sodium | ENOXAPARIN SODIUM | Fresenius Kabi USA, LLC | c3be543e-8aff-4311-bf77-e7a5a814ca6f | 2026-04-09 | Boxed warning, Warnings, Adverse reactions | ENOXAPARIN SODIUM |
| enoxaparin sodium | ENOXAPARIN SODIUM | BE Pharmaceuticals Inc. | b7197534-1daa-42de-8b83-a727da1195bf | 2026-03-01 | Boxed warning, Warnings, Adverse reactions | ENOXAPARIN SODIUM |
| Lovenox | ENOXAPARIN SODIUM | Sanofi-Aventis U.S. LLC | de6fb917-a94a-41ea-9d7d-937d4080ffcd | 2026-02-06 | Boxed warning, Warnings, Adverse reactions | Lovenox ENOXAPARIN SODIUM |
| Enoxaparin Sodium | ENOXAPARIN SODIUM | Fresenius Kabi USA, LLC | 21b095d1-5ade-43e9-9114-30fbfb2331c9 | 2026-02-04 | Boxed warning, Warnings, Adverse reactions | ENOXAPARIN SODIUM |
| Enoxaparin Sodium | ENOXAPARIN SODIUM | Fresenius Kabi USA, LLC | 066f27ec-352c-4051-ba29-248e292690db | 2026-02-04 | Boxed warning, Warnings, Adverse reactions | ENOXAPARIN SODIUM |
| ENOXAPARIN SODIUM | ENOXAPARIN SODIUM | Gland Pharma Limited | 65025e0d-eb54-4c4e-bd14-f294ce038902 | 2026-01-23 | Boxed warning, Warnings, Adverse reactions | ENOXAPARIN SODIUM |
| enoxaparin sodium | ENOXAPARIN SODIUM | Hebei Changshan Biochemical Pharmaceutical Co., Ltd. | 7fa78f8d-92d9-434a-8e26-b886ab0ae77f | 2026-01-14 | Boxed warning, Warnings, Adverse reactions | ENOXAPARIN SODIUM |
| Enoxaparin Sodium | ENOXAPARIN SODIUM | Meitheal Pharmaceuticals Inc. | b6fb85ab-1fe5-4dd3-a97f-adbed0674f67 | 2026-01-08 | Boxed warning, Warnings, Adverse reactions | ENOXAPARIN SODIUM |
| Enoxaparin Sodium | ENOXAPARIN SODIUM | Meitheal Pharmaceuticals Inc. | adbba7bb-fa72-4cec-aa69-13965591a45d | 2025-12-17 | Boxed warning, Warnings, Adverse reactions | ENOXAPARIN SODIUM |
| Enoxaparin Sodium | ENOXAPARIN SODIUM | BluePoint Laboratories | d978e06e-b758-460b-81d3-69f7a5b89b00 | 2025-09-30 | Boxed warning, Warnings, Adverse reactions | ENOXAPARIN SODIUM |
| Enoxaparin Sodium | ENOXAPARIN SODIUM | BluePoint Laboratories | a2a8615b-a27e-4ab2-ae4c-592bbf4643c0 | 2025-09-29 | Boxed warning, Warnings, Adverse reactions | ENOXAPARIN SODIUM |
| Enoxaparin Sodium | ENOXAPARIN SODIUM | Zydus Pharmaceuticals USA Inc. | d8afb29f-cbed-43bc-809f-09b30fca28f5 | 2024-12-06 | Boxed warning, Warnings, Adverse reactions | ENOXAPARIN SODIUM |
| Enoxaparin Sodium | ENOXAPARIN SODIUM | NorthStar Rx LLC | 32f8d292-0dda-4931-81ea-ba47e23edf61 | 2024-12-06 | Boxed warning, Warnings, Adverse reactions | ENOXAPARIN SODIUM |
| Enoxaparin Sodium | ENOXAPARIN SODIUM | Meitheal Pharmaceuticals Inc. | 7d38c307-767f-4c38-ac0e-b8bb62782602 | 2024-12-06 | Boxed warning, Warnings, Adverse reactions | ENOXAPARIN SODIUM |
| Enoxaparin Sodium | ENOXAPARIN SODIUM | NorthStar RxLLC | 014c6710-f2c4-fd1e-e063-6394a90ae525 | 2024-06-21 | Boxed warning, Warnings, Adverse reactions | ENOXAPARIN SODIUM |
| Enoxaparin Sodium | ENOXAPARIN SODIUM | Sandoz Inc | 38f60bd8-b518-4098-a808-b8f5a3ae6a3a | 2024-06-06 | Boxed warning, Warnings, Adverse reactions | ENOXAPARIN SODIUM |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.